Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial
Autor: | Soo Heon Kwak, Kyung Ah Han, Kyung‐Soo Kim, Jae Myung Yu, EunSook Kim, Jong Chul Won, Jun Goo Kang, Choon Hee Chung, Seungjoon Oh, Sung Hee Choi, Kyu Chang Won, Sin Gon Kim, Seung Ah Cho, Bo Young Cho, Kyong Soo Park |
---|---|
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Diabetes, Obesity and Metabolism. |
ISSN: | 1463-1326 1462-8902 |
Databáze: | OpenAIRE |
Externí odkaz: |